Patient Square Capital’s DBV Technologies DBVT Stock Holding History

Patient Square Capital’s Portfolio DBVT Stock Details DBVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9M	Buy	909,474 +215,940	+31%	+$4.07M	2.31%	11
2026 Q1	$14.5M	Buy	693,534 +334,484	+93%	+$6.99M	2.57%	10
2025 Q4	$6.88M	Buy	+359,050	New	+$5.61M	1.47%	14

Other funds holding DBVT

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Patient Square Capital's DBVT Position: Q2 2026 in Review

Patient Square Capital increased its DBV Technologies (DBVT) stake by 31% in Q2 2026, buying an estimated $4.07M and bringing the position to 909,474 shares worth $14.9M. The position accounts for 2.31% of the portfolio, ranked #11.

Patient Square Capital first reported a position in DBVT in Q4 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold DBVT as of Q2 2026.

Patient Square Capital held 909,474 shares of DBV Technologies worth $14.9M as of Q2 2026.
Patient Square Capital bought 215,940 DBV Technologies shares in Q2 2026, an estimated $4.07M.
DBV Technologies made up 2.31% of Patient Square Capital's portfolio in Q2 2026, its #11 holding.
Patient Square Capital first reported a position in DBV Technologies in Q4 2025 and has held it in 3 quarters since.
78 funds tracked by Wall St. Rank held DBV Technologies as of Q2 2026.

Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.